In vitro activity of tubercidin against Mycobacterium tuberculosis and nontuberculosis Mycobacteria

被引：2
|
作者：
Sun, Qing [1 ]
Liao, Xinlei [2 ]
Yan, Jun [2 ]
Jiang, Guanglu [1 ]
Huo, Fengmin [1 ]
Wang, Guirong [2 ]
Li, Hao [3 ,4 ]
机构：
[1] Capital Med Univ, Beijing TB & Thorac Tumor Inst, Beijing Chest Hosp, Natl Clin Lab TB, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Inst, Dept Clin Lab, Beijing, Peoples R China
[3] China Agr Univ, Coll Vet Med, Beijing, Peoples R China
[4] Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing, Peoples R China
来源：
JOURNAL OF MEDICAL MICROBIOLOGY | 2023年 / 72卷 / 11期
基金：
中国国家自然科学基金;
关键词：
tubercidin; Mycobacterium tuberculosis; nontuberculosis mycobacteria; tuberculosis; COMBINATION THERAPY; ABSORPTION; TOXICITY;
D O I：
10.1099/jmm.0.001763
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Tubercidin is an adenosine analogue that has been shown to exhibit good activity against some tumours and parasites. In this study, the in vitro activity of tubercidin was evaluated against Mycobacterium tuberculosis (Mtb) and nontuberculosis Mycobacteria (NTM). For determining the MICs of tubercidin, 23 fully drug- sensitive (DS) Mtb strains, 33 multi- drug resistance tubertuberculosis (XDR- TB) strains, 17 rapidly growing mycobacteria (RGM) and nine slowly growing mycobacteria (SGM) references strains were tested by microplate- based Alamar Blue assay (MABA) method. The results indicate that tubercidin has high in vitro activity against some drug- resistance Mtb strains and NTM reference strains, which warrants further investigation on the actions of tubercidin and its derivatives as potential drugs for mycobacterial infections.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis
    Guo, N.
    Wu, J.
    Fan, J.
    Yuan, P.
    Shi, Q.
    Jin, K.
    Cheng, W.
    Zhao, X.
    Zhang, Y.
    Li, W.
    Tang, X.
    Yu, L.
    LETTERS IN APPLIED MICROBIOLOGY, 2014, 58 (04) : 344 - 349
  • [22] Apramycin has high in vitro activity against Mycobacterium tuberculosis
    Sun, Qing
    Yan, Jun
    Long, Sibo
    Shi, Yiheng
    Jiang, Guanglu
    Li, Hao
    Huang, Hairong
    Wang, Guirong
    JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 73 (07)
  • [23] Antimycobacterial Activity of Hedeoma drummondii against Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria
    Molina-Torres, Carmen
    Pedraza-Rodriguez, Carlos
    Vera-Cabrera, Lucio
    Ocampo-Candiani, Jorge
    Rivas-Morales, Catalina
    Viveros-Valdez, Ezequiel
    ANTIBIOTICS-BASEL, 2023, 12 (05):
  • [24] Evaluation of Mycobacterium tuberculosis Culture and Drug Susceptibility Test Results and the Distribution of Nontuberculosis Mycobacteria from the Clinical Specimens
    Ozen, Nermin
    Atik, Tugba Kula
    Duran, Alev Cetin
    MIKROBIYOLOJI BULTENI, 2020, 54 (04): : 559 - 574
  • [25] In vitro evaluation of the antibacterial activity of nemonoxacin against Mycobacterium tuberculosis,Mycobacterium intracellulare and Mycobacterium abscessus
    姜广路
    China Medical Abstracts(Internal Medicine), 2021, 38 (01) : 41 - 41
  • [26] Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo
    Koga, T
    Fukuoka, T
    Doi, N
    Harasaki, T
    Inoue, H
    Hotoda, H
    Kakuta, M
    Muramatsu, Y
    Yamamura, N
    Hoshi, M
    Hirota, T
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) : 755 - 760
  • [27] NEOMYCIN ACTIVITY UPON MYCOBACTERIUM TUBERCULOSIS AND OTHER MYCOBACTERIA
    WAKSMAN, SA
    HUTCHISON, D
    KATZ, E
    AMERICAN REVIEW OF TUBERCULOSIS, 1949, 60 (01): : 78 - 89
  • [28] In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria
    Sohn, Hosung
    Lee, Kil-Soo
    Ko, Young-Kwan
    Ryu, Jae-Wook
    Woo, Jae-Choon
    Koo, Dong-Wan
    Shin, Sung-Jae
    Ahn, Se-Jin
    Shin, A-Rum
    Song, Chang-Hwa
    Jo, Eun-Kyeong
    Park, Jeong-Kyu
    Kim, Hwa-Jung
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (06) : 567 - 571
  • [29] The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review
    Andersson, Viktoria
    Froberg, Gabrielle
    Dahl, Victor
    Chryssanthou, Erja
    Giske, Christian
    Schon, Thomas
    Forsman, Lina
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2023, 12 (03) : 211 - 225
  • [30] BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis
    Richter, Adrian
    Seidel, Rudiger W.
    Goddard, Richard
    Eckhardt, Tamira
    Lehmann, Christoph
    Dorner, Julia
    Siersleben, Fabienne
    Sondermann, Theresia
    Mann, Lea
    Patzer, Michael
    Jager, Christian
    Reiling, Norbert
    Imming, Peter
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1302 - 1310
12345